Amgen 20 avr. 2026 Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen 16 avr. 2026 Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
BioPharma Dive 6 avr. 2026 Under-the-skin Tepezza comparable to infused version in key study, Amgen says
Endpoints News 6 avr. 2026 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
FierceBiotech 4 févr. 2026 Amgen advances toward lupus redemption while gastric cancer candidate struggles
FierceBiotech 30 janv. 2026 Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
FierceBiotech 13 janv. 2026 JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study
Endpoints News 12 déc. 2025 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
FierceBiotech 11 déc. 2025 Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx